Institut Pasteur

Institut Pasteur

Institut Pasteur

Overview
Date Founded

1887

Headquarters

25-28 rue du Docteur Roux Paris,, 75015, France

Charitable Causes

Philanthropy, Voluntarism, and Grantmaking Foundations

Industries

Investment Services & Portfolio Management

Company Description

The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris.

Contact Data
Trying to get in touch with decision makers at Institut Pasteur? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Financial Officer

Head of the Department of Neuroscience

Head-Immune Regulation & Vaccinology Unit

Head-Oncogenic Virus Epidemiology Unit

Director & Head-Structural Virology Unit

Director General

Treasurer & Director

Vice President-Research Assessment & Development

Director-Research Applications

Director, Research Unit Biodiversity & Epidemiology of Bacterial Pathogens

Board of Directors

Executive Director at SPB SA

Founder at Cellectis SA

Honorary Chairman at American Hospital of Paris

Group General Counsel at Ingenico Group SA

Head of the Department of Neuroscience at Institut Pasteur

Director at Institut Pasteur

Head-Immune Regulation & Vaccinology Unit at Institut Pasteur

Director & Head-Structural Virology Unit at Institut Pasteur

Head-Oncogenic Virus Epidemiology Unit at Institut Pasteur

Chairman & Chief Executive Officer at Centre National de la Recherche Scientifique

Distinguished Alumni
André Choulika is now Founder at Cellectis SA
Philippe Pouletty is now Co-Founder, Chief Executive Officer at Truffle Capital
Nicholas Paulmier is now Senior Partner at Cinven Ltd.
Paths to Institut Pasteur
Potential Connections via
Relationship Science
You
Institut Pasteur
Recent Transactions
Details Hidden

Société d'Economie Mixte purchases Société Civile Immobiliere from Institut Pasteur

Advisors & Consultants
Legal Advisor

Partner at Weil, Gotshal & Manges LLP

Legal Advisor

Partner at Hughes Hubbard & Reed LLP

Legal Advisor

Partner at Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Clients

bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in the development of potential gene therapies for severe genetic diseases and cancer. Its integrated product platform includes gene therapy, cancer immunotherapy and gene editing. Its product pipeline includes Lenti-D, LentiGlobin, BCL11a shRNA, bb2121, and bb21217. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Cambridge, MA.

Cellectis SA engages as a biopharmaceutical company that harnesses the immune system to target and eradicate cancer cells. It offers Gene editing and Immuno-oncology. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.

Deinove SA is a biotechnology company, which engages in the development of new-generation anti-infective antibiotics and bioactives. Its portfolio include Phy-N-Resist and HEBELYS. The company was founded by Philippe Pouletty and Miroslav Radman on October 11, 2006 and is headquartered in Grabels, France.

Non-Profit Donations & Grants Received
Investments
Details Hidden

Génomic Vision SA is a molecular diagnostics and technology company, which develops and commercializes research tools and tests for the early detection of cancers and genetic diseases. The firm's products include molecular combing platform and genomic morse code sets. The company was founded by Aaron Bensimon and Daniel Nerson on June 11, 2004 and is headquartered in Bagneux, France.

Details Hidden

Ariana Pharmaceuticals SA provides pharmaceutical, clinical and data technology. It offers analytics for multi-paramedic data in identifying patient responders to reduce clinical and drug development risk. The firm also develops biomarker signatures to develop processes in anawlyzing multi-paramedic data. The company was founded by Mohammad Afshar in 2003 and is headquartered in Paris, France.

Suppliers
IntegraGen SA Hospitals & Patient Services | Evry, France

IntegraGen SA engages in the development of genetic biomarkers. It also develops and markets molecular diagnostic products and services in the fields of autism and oncology. The company was founded by Jörg Hager on June 26, 2000 and is headquartered in Evry, France.

Genkyotex SA Biotechnology | Saint-julien-en-genevois, France

Genkyotex SA is a biopharmaceutical company that develops NOX therapies. Its therapeutic approach is based on a selective inhibition of NOX enzymes that amplify multiple disease processes, such as fibrosis, inflammation, pain processing, cancer development, and eurodegeneration. The company's platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes. The company's product candidate, setanaxib, a NOX1 and NOX4 inhibitor, demonstrated clinical evidence of anti-fibrotic activity in liver fibrosis patients in a phase II trial in primary biliary cholangitis. Genkyotex was founded in 2006 and is headquartered in Saint-Julien-en-Genevois, France.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Institut Pasteur. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Institut Pasteur's profile does not indicate a business or promotional relationship of any kind between RelSci and Institut Pasteur.